0001567619-20-020717.txt : 20201207 0001567619-20-020717.hdr.sgml : 20201207 20201207180200 ACCESSION NUMBER: 0001567619-20-020717 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201203 FILED AS OF DATE: 20201207 DATE AS OF CHANGE: 20201207 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kollins John A CENTRAL INDEX KEY: 0001391070 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39041 FILM NUMBER: 201373740 MAIL ADDRESS: STREET 1: SATSUMA PHARMACEUTICALS, INC. STREET 2: 400 OYSTER POINT BOULEVARD, SUITE 221 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Satsuma Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001692830 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 813039831 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 400 OYSTER POINT BOULEVARD STREET 2: SUITE 221 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 64080 BUSINESS PHONE: 415-505-0809 MAIL ADDRESS: STREET 1: 400 OYSTER POINT BOULEVARD STREET 2: SUITE 221 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 64080 4 1 doc1.xml FORM 4 X0306 4 2020-12-03 0 0001692830 Satsuma Pharmaceuticals, Inc. STSA 0001391070 Kollins John A C/O SATSUMA PHARMACEUTICALS, INC. 400 OYSTER POINT BOULEVARD, SUITE 221 SOUTH SAN FRANCISCO CA 94080 1 1 0 0 President and CEO Stock Option (Right to Buy) 4.60 2020-12-03 4 A 0 240000 0.00 A 2030-12-03 Common Stock 240000 240000 D Twenty Five Percent (25%) of the shares subject to the option vest one year measured from December 3, 2020 and the remaining shares subject to the option vest in 36 successive, equal monthly installments thereafter, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date. /s/ Thomas P. O'Neil as Attorney in Fact for John A. Kollins 2020-12-07